Net profit of Ind-Swift Laboratories declined 98.70% to Rs 0.41 crore in the quarter ended September 2024 as against Rs 31.66 crore during the previous quarter ended September 2023. Sales declined 95.87% to Rs 11.96 crore in the quarter ended September 2024 as against Rs 289.71 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales11.96289.71 -96 OPM %-98.6622.67 - PBDT0.8051.95 -98 PBT0.5838.77 -99 NP0.4131.66 -99 Powered by Capital Market - Live News

Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 11 November 2024.Powered by Capital Market - Live News

Ind-Swift Laboratories announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live News

Net profit of Ind-Swift Laboratories declined 94.55% to Rs 0.94 crore in the quarter ended June 2024 as against Rs 17.24 crore during the previous quarter ended June 2023. Sales declined 89.31% to Rs 33.17 crore in the quarter ended June 2024 as against Rs 310.34 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales33.17310.34 -89 OPM %-29.3619.43 - PBDT1.2345.52 -97 PBT0.9831.64 -97 NP0.9417.24 -95 Powered by Capital Market - Live News

Net profit of Ind-Swift Laboratories declined 63.70% to Rs 6.19 crore in the quarter ended June 2024 as against Rs 17.05 crore during the previous quarter ended June 2023. Sales declined 89.81% to Rs 30.46 crore in the quarter ended June 2024 as against Rs 299.01 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales30.46299.01 -90 OPM %-14.8720.01 - PBDT6.4444.99 -86 PBT6.1931.10 -80 NP6.1917.05 -64 Powered by Capital Market - Live News